Steven Cohen’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
22,514
+6,205
+38% +$625K ﹤0.01% 2319
2026
Q1
$1.44M Buy
16,309
+2,851
+21% +$246K ﹤0.01% 2523
2025
Q4
$1.06M Buy
+13,458
New +$1.02M ﹤0.01% 2840
2024
Q3
Sell
-7,841
Closed -$680K 2210
2024
Q2
$680K Sell
7,841
-12,925
-62% -$1.35M ﹤0.01% 1365
2024
Q1
$2.28M Buy
+20,766
New +$2.09M 0.01% 1221
2023
Q3
Sell
-100
Closed -$12.8K 2727
2023
Q2
$12.8K Sell
100
-17,800
-99% -$2.71M ﹤0.01% 1868
2023
Q1
$3.13M Sell
17,900
-60,114
-77% -$10.8M 0.01% 904
2022
Q4
$13M Buy
78,014
+41,855
+116% +$6.56M 0.04% 466
2022
Q3
$5.09M Buy
+36,159
New +$6.6M 0.02% 719

Other funds holding MLAB

Steven Cohen's MLAB Position: Q2 2026 in Review

Steven Cohen increased its Mesa Laboratories (MLAB) stake by 38% in Q2 2026, buying an estimated $625K and bringing the position to 22,514 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

Steven Cohen first reported a position in MLAB in Q3 2022 and has held it in 9 quarters since. The position peaked at $13M in Q4 2022. 157 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Steven Cohen held 22,514 shares of Mesa Laboratories worth $2.24M as of Q2 2026.
  • Steven Cohen bought 6,205 Mesa Laboratories shares in Q2 2026, an estimated $625K.
  • Mesa Laboratories made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2319 holding.
  • Steven Cohen first reported a position in Mesa Laboratories in Q3 2022 and has held it in 9 quarters since.
  • Steven Cohen's Mesa Laboratories position peaked at $13M in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.